PENSACOLA, Fla. (WEAR) — Half a million people this year will get an infection called C. diff. It ranges from uncomfortable to life-threatening. And in more and more cases, doctors are turning to an ...

Rebiotix, a Ferring Company, and its parent Ferring Pharmaceuticals Group said today their microbiome-based treatment candidate RBX2660 showed positive preliminary Phase III results in patients with ...

Finally, some good news about a Cliff. After two months of training, a two-year-old beagle named Cliff demonstrated success at being able to detect C. diff in stool samples in a lab environment, ...

STATEN ISLAND, N.Y., Sept. 30, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (ACXP) ("Acurx" or the "Company") is a late-stage biopharmaceutical company developing a new class of small molecule ...

Known as one of the superbugs that resists most antibiotics, Clostridioides difficile, or C. diff, causes inflammation of the colon and can lead to diarrhea and sometimes death. The stubborn bacteria ...

Patients who undergo emergency general surgery have a high incidence of Clostridium difficile infection, a study published in Surgical Infections found. The researchers looked at 550 patients with ...